Search details
1.
Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
Mol Vis
; 26: 641-651, 2020.
Article
in English
| MEDLINE | ID: mdl-33088168
2.
TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.
Eur J Immunol
; 48(11): 1810-1816, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30218573
3.
Shedding New Light on the Process of "Licensing" for Pathogenicity by Th Lymphocytes.
J Immunol
; 198(2): 681-690, 2017 01 15.
Article
in English
| MEDLINE | ID: mdl-27986906
4.
Unlike Th1/Th17 cells, Th2/Th9 cells selectively migrate to the limbus/conjunctiva and initiate an eosinophilic infiltration process.
Exp Eye Res
; 166: 116-119, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29074386
5.
Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.
Proc Natl Acad Sci U S A
; 112(13): 4080-5, 2015 Mar 31.
Article
in English
| MEDLINE | ID: mdl-25775512
6.
The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
J Immunol
; 194(8): 3567-82, 2015 Apr 15.
Article
in English
| MEDLINE | ID: mdl-25786692
7.
Differential involvement of Th1 and Th17 in pathogenic autoimmune processes triggered by different TLR ligands.
J Immunol
; 191(1): 415-23, 2013 Jul 01.
Article
in English
| MEDLINE | ID: mdl-23720812
8.
Induced regulatory T-cells (iTregs) generated by activation with anti-CD3/CD28 antibodies differ from those generated by the physiological-like activation with antigen/APC.
Cell Immunol
; 290(2): 179-84, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-25038545
9.
Cell-cell interaction with APC, not IL-23, is required for naive CD4 cells to acquire pathogenicity during Th17 lineage commitment.
J Immunol
; 189(3): 1220-7, 2012 Aug 01.
Article
in English
| MEDLINE | ID: mdl-22745380
10.
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.
Nat Med
; 13(6): 711-8, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17496900
11.
Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes.
Immunology
; 140(4): 475-82, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23906311
12.
The unique features of Th9 cells and their products.
Crit Rev Immunol
; 32(1): 1-10, 2012.
Article
in English
| MEDLINE | ID: mdl-22428852
13.
SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Mol Vis
; 18: 1858-64, 2012.
Article
in English
| MEDLINE | ID: mdl-22815639
14.
Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site.
J Immunol
; 185(11): 6795-801, 2010 Dec 01.
Article
in English
| MEDLINE | ID: mdl-20971929
15.
Correction: The TNF-Family Ligand TL1A and Its Receptor DR3 Promote T Cell-Mediated Allergic Immunopathology by Enhancing Differentiation and Pathogenicity of IL-9-Producing T Cells.
J Immunol
; 195(12): 5839-40, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26637663
16.
Inflammation-inducing Th1 and Th17 cells differ in their expression patterns of apoptosis-related molecules.
Cell Immunol
; 271(2): 210-3, 2011.
Article
in English
| MEDLINE | ID: mdl-21903206
17.
Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death.
J Immunol
; 183(11): 7547-56, 2009 Dec 01.
Article
in English
| MEDLINE | ID: mdl-19890052
18.
Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells.
J Immunol
; 181(10): 7205-13, 2008 Nov 15.
Article
in English
| MEDLINE | ID: mdl-18981142
19.
Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune Uveitis.
Front Immunol
; 11: 583510, 2020.
Article
in English
| MEDLINE | ID: mdl-33569048
20.
Type I Interferon Therapy Limits CNS Autoimmunity by Inhibiting CXCR3-Mediated Trafficking of Pathogenic Effector T Cells.
Cell Rep
; 28(2): 486-497.e4, 2019 07 09.
Article
in English
| MEDLINE | ID: mdl-31291583